Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas (scientific article published on 4 May 2017)

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

Q29615800

Supervised risk predictor of breast cancer based on intrinsic subtypes

Q29617404

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status

Q30665329

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

Q33330850

Differences in the tumor microenvironment between African-American and European-American breast cancer patients

Q33410258

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.

Q33573884

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.

Q33669007

Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women

Q33975072

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.

Q33983489

Differential gene expression between African American and European American colorectal cancer patients.

Q34140368

Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer

Q34278253

Epidemiology of basal-like breast cancer

Q34639174

Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer

Q35064200

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

Q35089479

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Q35557782

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer

Q35755874

Race-associated biological differences among Luminal A breast tumors

Q35922859

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Q35996692

Prediction of breast cancer risk based on profiling with common genetic variants

Q36583004

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence

Q37163880

Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

Q37564081

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

Q37624199

The intersection of neighborhood racial segregation, poverty, and urbanicity and its impact on food store availability in the United States

Q37674777

A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change

Q38470766

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

Q39605778

Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer

Q40346126

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Q40379855

Differences in risk factors for breast cancer molecular subtypes in a population-based study

Q42509874

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

Q42510173

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival

Q42520439

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

Q44513168

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

Q80358653

P921

main subject

The Cancer Genome Atlas

Q3979425

P577

publication date

2017-05-04

P1433

published in

JAMA Oncology

Q22079683

P1476

title

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas

Reverse relations

cites work (P2860)

Q90066927	A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer
Q52602395	An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Q89519934	Association between metabolic syndrome and prognosis of breast cancer: a meta-analysis of follow-up studies
Q45945284	Big data management challenges in health research-a literature review.
Q99631327	Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care
Q100467277	Body fatness and mTOR pathway activation of breast cancer in the Women's Circle of Health Study
Q46371399	Breast cancer in Latinas: a focus on intrinsic subtypes distribution
Q88801211	Breast cancer metastasis through the lympho-vascular system
Q47621558	Breast cancer statistics, 2017, racial disparity in mortality by state.
Q92693399	Breast cancer subtypes among Eastern-African-born black women and other black women in the United States
Q99234116	Cancer health disparities in racial/ethnic minorities in the United States
Q57459354	Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Q89944923	Comparison of pathway and gene-level models for cancer prognosis prediction
Q58605149	Decelerated DNA methylation age predicts poor prognosis of breast cancer
Q41717198	Development and clinical application of radiomics in lung cancer
Q57468209	Differences in microRNA expression in breast cancer between women of African and European ancestry
Q64979575	Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts.
Q58732674	Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry
Q92582927	Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
Q97870460	Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions
Q90185347	High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer
Q49890391	Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.
Q57293734	Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers
Q89717694	Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
Q57805731	LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications
Q61447145	Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study
Q55156355	Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.
Q57043540	Multicenter Study Using Desorption-Electrospray-Ionization-Mass-Spectrometry Imaging for Breast-Cancer Diagnosis
Q47691368	Mutations in context: implications of BRCA testing in diverse populations
Q90171553	Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana
Q64926956	PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.
Q91831567	Pathology of Senegalese breast cancers
Q50059089	Population-dependent Intron Retention and DNA Methylation in Breast Cancer.
Q47213433	Prioritizing diversity in human genomics research.
Q92238649	Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ
Q47124829	Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study
Q50003979	Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.
Q55101274	Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening.
Q93006397	Searching for the value of accountable care organizations in cancer care
Q92619432	Survival pattern of rare histological types of breast cancer in a Nigerian institution
Q55287276	TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
Q90026659	The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic U.S. Population
Q64078966	Therapeutic Clues from an Integrated Omic Assessment of East Asian Triple Negative Breast Cancers
Q64106473	Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene
Q98467125	Understanding breast cancer disparities-a multi-scale challenge

P356	DOI	10.1001/JAMAONCOL.2017.0595
P932	PMC publication ID	5671371
P698	PubMed publication ID	28472234